Clinical Trial Update: Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining lipopolysaccharide binding protein and infectious events in cirrhotic patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Snippet

Sponsor: Florencia Vargas-Vorackova | Conditions: Cirrhosis, Ascites | Phase 4 | Status: WITHDRAWN